Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
{{output}}
Background: A clinical ability to describe the response trajectory of patients receiving preventive migraine treatment could expedite and improve therapeutic management decisions. This post hoc analysis of the PROMISE-2 study eva... ...
